Б. С. Белов

511 total citations
152 papers, 295 citations indexed

About

Б. С. Белов is a scholar working on Rheumatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Б. С. Белов has authored 152 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Rheumatology, 41 papers in Epidemiology and 29 papers in Infectious Diseases. Recurrent topics in Б. С. Белов's work include Rheumatoid Arthritis Research and Therapies (48 papers), Autoimmune and Inflammatory Disorders Research (23 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Б. С. Белов is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (48 papers), Autoimmune and Inflammatory Disorders Research (23 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Б. С. Белов collaborates with scholars based in Russia, United Kingdom and Czechia. Б. С. Белов's co-authors include А. Е. Каратеев, А. М. Лила, Е. Л. Насонов, Д. И. Абдулганиева, Т. В. Попкова, С. И. Глухова, А. А. Баранов, N. N. Kuzmina, Mazurov Vi and Sergey Moiseev and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Terapevticheskii arkhiv.

In The Last Decade

Б. С. Белов

88 papers receiving 225 citations

Peers

Б. С. Белов

RHEUM

HEMAT

EPIDE

IMMUN

Alina Boteanu Spain

Naomi J. Patel United States

Ivan Leonardo Avelino França e Silva Brazil

Lorenza Maria Argolini Italy

Jan Zernicke Germany

Butsabong Lerkvaleekul Thailand

Christian Holkmann Olsen Denmark

Emily Figueiredo Neves Yuki Brazil

Francisco Javier Gil‐Etayo Spain

Merav Heshin‐Bekenstein Israel

Alina Boteanu Spain

Б. С. Белов

93 ×0.6

RHEUM

68 ×0.8

HEMAT

101 ×1.2

19 ×0.4

EPIDE

48 ×1.0

IMMUN

Citations per year, relative to Б. С. Белов Б. С. Белов (= 1×) peers Alina Boteanu

Countries citing papers authored by Б. С. Белов

Since Specialization

Citations

This map shows the geographic impact of Б. С. Белов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Б. С. Белов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Б. С. Белов more than expected).

Fields of papers citing papers by Б. С. Белов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Б. С. Белов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Б. С. Белов. The network helps show where Б. С. Белов may publish in the future.

Co-authorship network of co-authors of Б. С. Белов

This figure shows the co-authorship network connecting the top 25 collaborators of Б. С. Белов. A scholar is included among the top collaborators of Б. С. Белов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Б. С. Белов. Б. С. Белов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Белов, Б. С., et al.. (2024). Efficacy, Immunogenicity, and Safety of the Combined Vector Vaccine Gam-COVID-Vac in Patients with Rheumatic Diseases. Antibiot Khimioter = Antibiotics and Chemotherapy. 69(7-8). 44–52.

Белов, Б. С., et al.. (2024). Experience with 23-valent pneumococcal polysaccharide vaccine in patients with ankylosing spondylitis and psoriatic arthritis. Medical alphabet. 15–20. 1 indexed citations

Белов, Б. С., et al.. (2024). Risk factors for severe COVID-19 in patients with rheumatic diseases. SHILAP Revista de lepidopterología. 62(1). 24–31.

Белов, Б. С., et al.. (2024). Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis. SHILAP Revista de lepidopterología. 62(3). 293–299.

Белов, Б. С., et al.. (2023). Post-Covid syndrome: clinical picture, diagnosis and treatment from a rheumatologist perspective. SHILAP Revista de lepidopterología. 17(6). 7–13.

Белов, Б. С., et al.. (2023). Rheumatoid arthritis and COVID-19: Three years later. SHILAP Revista de lepidopterología. 61(4). 450–457.

Белов, Б. С., et al.. (2023). Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use. SHILAP Revista de lepidopterología. 61(3). 330–338. 1 indexed citations

Белов, Б. С., et al.. (2023). Comorbid infections in patients with spondyloarthritis: frequency, structure and risk factors. SHILAP Revista de lepidopterología. 17(4). 64–70. 1 indexed citations

Белов, Б. С., et al.. (2023). Frequency and course of COVID-19 in patients with rheumatic diseases (according to the data of V.A. Nasonova Research Institute of Rheumatology). SHILAP Revista de lepidopterología. 61(5). 537–544. 1 indexed citations

10.

Белов, Б. С., et al.. (2023). The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news. SHILAP Revista de lepidopterología. 61(3). 268–275.

11.

Белов, Б. С., et al.. (2022). Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data). SHILAP Revista de lepidopterología. 16(1). 26–31. 2 indexed citations

12.

Белов, Б. С., et al.. (2022). Pneumococcal vaccination in rheumatic diseases: 10 years of application experience at the V.A. Nasonova Research Institute of Rheumatology. SHILAP Revista de lepidopterología. 60(3). 261–266. 2 indexed citations

13.

Белов, Б. С., et al.. (2022). Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data. SHILAP Revista de lepidopterología. 67(7-8). 33–39.

14.

Белов, Б. С., et al.. (2021). Use of Janus kinase inhibitors in the treatment of immunoinflammatory rheumatic diseases: safety issues. SHILAP Revista de lepidopterología. 76–84. 1 indexed citations

15.

Насонов, Е. Л., et al.. (2021). Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review. SHILAP Revista de lepidopterología. 59(6). 666–675. 11 indexed citations

16.

Белов, Б. С., et al.. (2021). The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data). SHILAP Revista de lepidopterología. 122–126. 2 indexed citations

17.

Белов, Б. С., et al.. (2016). Comorbid infections in patients with systemic lupus erythematosus: State-of-the-art. Rheumatology Science and Practice. 54(4). 469–477.

18.

Белов, Б. С., et al.. (2016). Новые критерии диагностики острой ревматической лихорадки (предложения Американской ассоциации сердца по пересмотру критериев Джонса).

19.

Белов, Б. С.. (2014). BIOLOGICAL THERAPY AND INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RELEVANCE AND PROSPECTS. SHILAP Revista de lepidopterología.

20.

Белов, Б. С., et al.. (2007). A STREPTOCOCCAL TONSILLITIS: MODERN ASPECTS OF ANTIBACTERIAL THERAPY. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact